Chemoinformaics analysis of 2,3-DIHYDROOCHNAFLAVONE 7-O-METHYL ETHER
| Molecular Weight | 554.507 | nRot | 5 |
| Heavy Atom Molecular Weight | 532.331 | nRig | 36 |
| Exact Molecular Weight | 554.121 | nRing | 6 |
| Solubility: LogS | -5.544 | nHRing | 2 |
| Solubility: LogP | 5.789 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 5 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 28 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 29 |
| nHA | 10 | APOL | 74.4594 |
| nHD | 4 | BPOL | 30.7506 |
| QED | 0.21 |
| Synth | 3.384 |
| Natural Product Likeliness | 1.337 |
| NR-PPAR-gamma | 0.986 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.081 |
| Pgp-sub | 0.009 |
| HIA | 0.188 |
| CACO-2 | -5.122 |
| MDCK | 0.0000169 |
| BBB | 0.003 |
| PPB | 0.983867 |
| VDSS | 0.387 |
| FU | 0.0220438 |
| CYP1A2-inh | 0.659 |
| CYP1A2-sub | 0.471 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.878 |
| CYP2c9-sub | 0.959 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.864 |
| CYP3a4-inh | 0.495 |
| CYP3a4-sub | 0.14 |
| CL | 5.691 |
| T12 | 0.297 |
| hERG | 0.084 |
| Ames | 0.556 |
| ROA | 0.936 |
| SkinSen | 0.949 |
| Carcinogencity | 0.355 |
| EI | 0.897 |
| Respiratory | 0.44 |
| NR-Aromatase | 0.848 |
| Antiviral | Yes |
| Prediction | 0.674736 |